"Het Erasmus MC Sophia Kinderziekenhuis heeft alles in huis om uw kind de beste zorg te bieden. Het is een innovatief kinderziekenhuis, dat al meer dan 150 jaar bestaat. Alle specialismen op het gebied van kindergeneeskunde, chirurgie en kinderpsychiatrie zijn aanwezig. Ook zijn de afdelingen Verloskunde en Gynaecologie, Klinische Genetica en Urologie aanwezig in en onderdeel van het Erasmus MC-Sophia. De kennis van alle vakgebieden in het kinderziekenhuis komt samen in vier speerpunten: het Kinderthoraxcentrum, het Kinderhersencentrum, het Centrum voor Zeldzame ziekten en het Centrum voor reproductieve, foetale en neonatale geneeskunde."

During the past decade, Erasmus MC - Sophia Children's Hospital conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 5 clinical trials were completed, i.e. on average, 35.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Erasmus MC - Sophia Children's Hospital" #1 sponsor was "Erasmus Medical Center" with 4 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 4 trials sponsored, "Gustave Roussy, Cancer Campus, Grand Paris" with 3 trials sponsored, "Dutch Childhood Oncology Group" with 2 trials sponsored and "Amgen Research (Munich) GmbH" with 2 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Erasmus MC - Sophia Children's Hospital" #1 collaborator was "Erasmus Medical Center" with 3 trials as a collaborator, "ZonMw: The Netherlands Organisation for Health Research and Development" with 3 trials as a collaborator, "Amsterdam UMC, location VUmc" with 1 trials as a collaborator, "Arbeitsgemeinschaft fur Internistische Onkologie" with 1 trials as a collaborator and "Associazione Italiana Ematologia Oncologia Pediatrica" with 1 trials as a collaborator. Other collaborators include 64 different institutions and companies that were collaborators in the rest 74 trials.

According to Clinical.Site data, the most researched conditions in "Erasmus MC - Sophia Children's Hospital" are "Leukemia" (3 trials), "Fallopian Tube Cancer" (2 trials), "Lymphoma" (2 trials), "Myelodysplastic Syndromes" (2 trials) and "Ovarian Cancer" (2 trials). Many other conditions were trialed in "Erasmus MC - Sophia Children's Hospital" in a lesser frequency.

Most popular intervention types in "Erasmus MC - Sophia Children's Hospital" are "Drug" (21 trials), "Procedure" (8 trials), "Biological" (6 trials), "Other" (5 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "vincristine sulfate" (4 trials), "allogeneic hematopoietic stem cell transplantation" (3 trials), "cyclophosphamide" (3 trials), "cytarabine" (3 trials) and "leucovorin calcium" (3 trials). Other intervention names were less common.

The vast majority of trials in "Erasmus MC - Sophia Children's Hospital" are 30 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Erasmus MC - Sophia Children's Hospital". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Erasmus MC - Sophia Children's Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Erasmus MC - Sophia Children's Hospital, 5 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".